Bock Hans Christoph, Kanzler Maximilian, Thomale Ulrich-Wilhelm, Ludwig Hans Christoph
Department of Neurosurgery, Section Pediatric Neurosurgery, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Abteilung Neurochirurgie, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Childs Nerv Syst. 2018 Mar;34(3):457-464. doi: 10.1007/s00381-017-3654-0. Epub 2017 Nov 9.
Treatment monitoring and outcome evaluation in pediatric hydrocephalus require gapless documentation regarding surgical and clinical follow-up data beginning from day 1 of treatment in order to apply high quality of care. Endoscopic procedures, shunt insertion and revision surgeries, and individual modifications of valve hardware or pressure settings during follow-up as well as established outcome measurements are highly relevant for complete illustration of the patient's hydrocephalus histories. A digital tool to capture, organize, and analyze comprehensive treatment-related data was estimated long overdue, consequentially developed, and implemented in daily pediatric neurosurgical routine.
We established a self-contained, network-capable database application to supply and back up clinical information of complete surgical treatment history with implant status and follow up for all institutional pediatric hydrocephalus patients from 1995 to date. The application content has been prospectively complemented since 2012 during daily pediatric neurosurgical routine. Beside surgical data, neurological outcome and quality of life assessment were integrated according to validated scales to be recordable 2, 3, and 5 years after initial surgical intervention for prospective administration. The application is in continuous and problem-free use since implementation offering homogeneous and structured real-time information of surgical and corresponding neurological hydrocephalus-related data. By using an automatized data extraction tool, an exemplary surgical outcome evaluation reviewing institutional ventriculo-peritoneal shunt (VPS) treatment in infants over a period of more than 20 years was performed. To validate applicability, the Registry was successfully implemented in an external institution under identical conditions continuously serving for the same purpose until today.
Upon completion of the developing process, the application was successfully implemented into routine clinical workflow of our institution. In total, 579 pediatric hydrocephalus patients entered into the Registry with collectively 1874 corresponding hydrocephalus-related surgeries (9% neuro-endoscopic procedures, 18% temporary CSF-diversions, 73% shunt surgeries) so far. For exemplary surgical outcome analysis, the total volume of complex data sets could easily be reduced stepwise in regard to requested inclusion criteria. The selection process generated conclusive data of 256 institutional pediatric VPS patients providing a median follow-up of 8.5 years. Surgical outcome was evaluated in regard to hydrocephalus etiology, applied valve design, valve augmentation, cause of initial malfunction, time to initial shunt revision, and number of total revisions.
The pediatric hydrocephalus registry application delivers easy access to contemporary and up-to-date clinical information during daily clinical routine and proves comprehensive value for various scientific purposes. Institutional hydrocephalus etiologies, treatment modalities, and surgical outcome could be reviewed for a selected pediatric patient collective during an interval of more than 20 years and confirmed initial shunt treatment within the first year of age, communicating hydrocephalus and a history of prematurity as significant variables for unfavorable shunt survival and long-term revision rate. At our institution, the Registry emerged to an essential and sustainable tool to capture, organize, and analyze patterns of care in pediatric hydrocephalus patients of all etiologies and treatment modalities. Because of its adaptable and reliable predicate, a prospective multi-center utilization is currently in preparation.
小儿脑积水的治疗监测和结果评估需要从治疗第1天开始就无缝记录手术和临床随访数据,以便提供高质量的护理。内镜手术、分流管植入和翻修手术,以及随访期间瓣膜硬件或压力设置的个体化调整,以及既定的结果测量,对于完整呈现患者的脑积水病史高度相关。一个用于捕获、整理和分析全面治疗相关数据的数字工具早就被认为是迫切需要的,因此得以开发并应用于日常小儿神经外科诊疗中。
我们建立了一个独立的、具备网络功能的数据库应用程序,用于提供和备份1995年至今所有机构内小儿脑积水患者完整手术治疗史的临床信息,包括植入状态和随访情况。自2012年起,在日常小儿神经外科诊疗过程中前瞻性地补充应用内容。除手术数据外,还根据经过验证的量表纳入神经学结果和生活质量评估,以便在初次手术干预后2、3和5年进行前瞻性记录。该应用程序自实施以来一直在持续且无故障地使用,提供关于手术及相应神经学脑积水相关数据的统一且结构化的实时信息。通过使用自动化数据提取工具,对超过20年期间机构内婴儿的脑室-腹腔分流术(VPS)治疗进行了示例性手术结果评估。为验证适用性,该注册系统已在外部机构成功实施,在相同条件下持续用于相同目的直至今日。
在开发过程完成后,该应用程序成功应用于我们机构的日常临床工作流程。到目前为止,共有579例小儿脑积水患者进入该注册系统,共有1874例与之相关的脑积水手术(9%为神经内镜手术,18%为临时脑脊液分流术,73%为分流手术)。对于示例性手术结果分析,复杂数据集的总量可根据所需纳入标准轻松逐步减少。筛选过程产生了256例机构内小儿VPS患者的确切数据,中位随访时间为8.5年。从脑积水病因、应用的瓣膜设计、瓣膜增强、初次故障原因、初次分流管翻修时间和总翻修次数等方面评估了手术结果。
小儿脑积水注册应用程序在日常临床诊疗中可轻松获取当代最新临床信息,并在各种科学目的方面具有全面价值。在超过20年的时间间隔内,可对选定的小儿患者群体的机构内脑积水病因、治疗方式和手术结果进行回顾,并确认1岁以内的初次分流治疗、交通性脑积水和早产史是分流管存活不良和长期翻修率的重要变量。在我们机构,该注册系统已成为捕获、整理和分析所有病因和治疗方式的小儿脑积水患者护理模式的重要且可持续的工具。由于其适应性强且可靠,目前正在筹备进行前瞻性多中心应用。